Teleflex (NYSE:TFX) subsidiary NeoTract said that two more health insurers have agreed to offer coverage for the company’s UroLift system or patients with an enlarged prostate. The Wayne, Penn.-based subsidiary of Teleflex said that major U.S. insurer Humana and the Motion Picture Industry Pension & Health Plans (MPI), administered by Anthem Blue Cross, have added UroLift to its […]
NeoTract
Teleflex’s NeoTract wins Japanese approval for UroLift BPH treatment system
Teleflex (NYSE:TFX) subsidiary NeoTract said today it won Shonin approval from Japan’s Ministry of Health, Labor and Welfare for its Urolift system intended for treating benign prostatic hyperplasia. The UroLift system uses tiny devices inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the enlarged prostate, the Pleasanton, Calif.-based […]
NeoTract says real-world prostate study beats clinical trial results
A study evaluating NeoTract’s UroLift treatment for men with enlarged prostate glands showed a 62% improvement in lower urinary tract symptoms, the company said today. The real-world study enrolled 100 men with benign prostatic hyperplasia (BPH) at a single center. Peak flow rate improved 140% and the post-void residual volume (PVR) decreased by 71 ml, with […]
Teleflex’s NeoTract touts data from multiple UroLift BPH-treatment studies
Teleflex (NYSE:TFX) subsidiary NeoTract this week presented results from a number of studies of its UroLift system, touting cost reductions and quality of life improvements. The Wayne, Penn.-based company said it presented data from seven studies of the UroLift system exploring its use for patients with benign prostatic hyperplasia at the World Congress of Endourology 2018 annual conference […]
Teleflex’s NeoTract wins AUA support for UroLift system as standard-of-care
Teleflex (NYSE:TFX) subsidiary NeoTract said today that the American Urological Association now recommends the use of NeoTract’s UroLift system as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. The company’s UroLift system uses tiny devices inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside […]
Teleflex’s NeoTract wins expanded FDA indication for UroLift prostate device
Teleflex (NYSE:TFX) subsidiary NeoTract said yesterday that it won expanded indications from the FDA for its UroLift prostate treatment. Previously approved for treating benign prostate hyperplasia in men 50 and over without an obstructive median lobe, the new indications open the treatment to patients 45 or older with an obstructive median lobe. UroLift uses tiny devices inserted into the urethra […]
Teleflex closes $1B NeoTract buy
Teleflex (NYSE:TFX) said today that it closed its $1.1 billion acquisition of NeoTract and its UroLift prostate treatment. The deal called for an up-front cash payment of $725 million, plus another $375 million in milestone payments pegged to sales numbers through 2020, Wayne, Pa.-based Teleflex said. The UroLift system for benign prostate hyperplasia uses tiny devices that are […]
Teleflex to pay $1.1B for NeoTract
Teleflex (NYSE:TFX) said today that it agreed to put up $1.1 billion to acquire NeoTract and its UroLift prostate treatment. The deal calls for an up-front cash payment of $725 million, plus another $375 million in milestone payments pegged to sales numbers through 2020, Wayne, Pa.-based Teleflex said. The deal is expected to close within 30 days. The […]
7 medtech stories we missed this week: July 7, 2017
From EnvisionTEC’s FDA approval to InVivo Therapeutics adding a new clinical site, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EnvisionTEC wins FDA nod for 3D printing E-Denture material EnvisionTEC announced in a June 30 press release that it has received FDA approval for its E-Denture material […]
NeoTract touts 5-year UroLift study data
NeoTract today presented 5-year results from the pivotal Lift IDE study of its UroLift system, touting rapid reduction of symptoms and sustained effects in treating patients with symptomatic benign prostatic hyperplasia. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract […]
7 medtech stories we missed this week: March 31, 2017
This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are 7 medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press […]